Abstract:Abstract Background 1-Hydroxyphenazine (1-OH-PHZ) is a phenazine microbial metabolite with broad-spectrum antibacterial activities against a lot of plant pathogens. However, its use is hampered by the low yield all along. Metabolic engineering of microorganisms is an increasingly powerful method for the production of valuable organisms at high levels. Pseudomonas chlororaphis is recognized as a safe and effective plant rhizosphere growth-promoting bacterium, and faster growth rate using glycerol or glucose as a renewable carbon source. Therefore, Pseudomonas chlororaphis is particularly suitable as the chassis cell for the modification and engineering of phenazines. Results In this study, enzyme PhzS (monooxygenase) was heterologously expressed in a phenazine-1-carboxylic acid (PCA) generating strain Pseudomonas chlororaphis H18, and 1-hydroxyphenazine was isolated, characterized in the genetically modified strain. Next, the yield of 1-hydroxyphenazine was systematically engineered by the strategies including (1) semi-rational design remodeling of crucial protein PhzS, (2) blocking intermediate PCA consumption branch pathway, (3) enhancing the precursor pool, (4) engineering regulatory genes, etc. Finally, the titer of 1-hydroxyphenazine reached 3.6 g/L in 5 L fermenter in 54 h. Conclusions The 1-OH-PHZ production of Pseudomonas chlororaphis H18 was greatly improved through systematically engineering strategies, which is the highest, reported to date. This work provides a promising platform for 1-hydroxyphenazine engineering and production. Graphical Abstract

The biosynthesis of natural phenazine

Biosynthesis and Genetic Engineering of Polyketides

Recent Advances in Phenazine Natural Products: Biosynthesis and Metabolic Engineering

Recent Advances in Phenazine Natural Products: Chemical Structures and Biological Activities

Synthesis and Application of Phenothiazines and Their Derivatives

Synthesis and Pesticidal Activities of New Quinoxalines

Progress in Plant Phenolic Compounds

In vivo and in vitro reconstitution of biosynthesis of N‐prenylated phenazines revealing diverse phenazine‐modifying enzymes

Advances in Phenazines over the Past Decade: Review of Their Pharmacological Activities, Mechanisms of Action, Biosynthetic Pathways and Synthetic Strategies

Genome Mining Enabled by Biosynthetic Characterization Uncovers a Class of Benzoxazolinate‐Containing Natural Products in Diverse Bacteria

Dual phenazine gene clusters enable diversification during biosynthesis

Isolation and Biosynthesis of Phenazine–Polyketide Hybrids from Streptomyces sp. KIB-H483

Development of Artificial Synthetic Pathway of Endophenazines in Pseudomonas chlororaphis P3

Bioactive Phenazines from an Earwig-Associated Streptomyces Sp.

Biosynthesis Investigations of Terpenoid, Alkaloid, and Flavonoid Antimicrobial Agents Derived from Medicinal Plants

The biosynthesis of L -phenylalanine-derived compounds by engineered microbes

Biosynthesis and metabolic engineering of 1-hydroxyphenazine in Pseudomonas chlororaphis H18

Biocontrol ability of phenazine-producing strains for the management of fungal plant pathogens: A review

Global landscape of phenazine biosynthesis and biodegradation reveals species-specific colonization patterns in agricultural soils and crop microbiomes

Activation of a silent phenazine biosynthetic gene cluster reveals a novel natural product and a new resistance mechanism against phenazines

Simple phenylpropanoids: recent advances in biological activities, biosynthetic pathways, and microbial production